To examine the in vivo role(s) of type I interferons (IFNs) and to determine the role of a component of the type I IFN receptor (IFNAR1) in mediating responses to these IFNs, we generated mice with a null mutation (-/-) in the IFNAR1 gene. Despite compelling evidence for modulation of cell proliferation and differentiation by type I IFNs, there were no gross signs of abnormal fetal development or morphological changes in adult IFNAR1 -/-mice. However, abnormalities of hemopoietic cells were detected in IFNAR1 -/-mice. Elevated levels of myeloid lineage cells were detected in peripheral blood and bone marrow by staining with Mac-i and Gr-1 antibodies. Furthermore, bone marrow macrophages from IFNAR1 -/-mice showed abnormal responses to colony-stimulating factor 1 and lipopolysaccharide. IFNAR1 -/-mice were highly susceptible to viral infection: viral titers were undetected 24 hr after infection of IFNAR1 +/+ mice but were extremely high in organs of IFNAR1-/-mice, demonstrating that the type I IFN system is a major acute antiviral defence. In cell lines derived from IFNAR1 -/-mice, there was no signaling in response to IFN-a or -,B as measured by induction of 2'-5' oligoadenylate synthetase, antiviral, or antiproliferative responses. Importantly, these studies demonstrate that type I IFNs function in the development and responses of myeloid lineage cells, particularly macrophages, and that the IFNAR1 receptor component is essential for antiproliferative and antiviral responses to IFN-a and -1.
ABSTRACT
To examine the in vivo role(s) of type I interferons (IFNs) and to determine the role of a component of the type I IFN receptor (IFNAR1) in mediating responses to these IFNs, we generated mice with a null mutation (-/-) in the IFNAR1 gene. Despite compelling evidence for modulation of cell proliferation and differentiation by type I IFNs, there were no gross signs of abnormal fetal development or morphological changes in adult IFNAR1 -/-mice. However, abnormalities of hemopoietic cells were detected in IFNAR1 -/-mice. Elevated levels of myeloid lineage cells were detected in peripheral blood and bone marrow by staining with Mac-i and Gr-1 antibodies. Furthermore, bone marrow macrophages from IFNAR1 -/-mice showed abnormal responses to colony-stimulating factor 1 and lipopolysaccharide. IFNAR1 -/-mice were highly susceptible to viral infection: viral titers were undetected 24 hr after infection of IFNAR1 +/+ mice but were extremely high in organs of IFNAR1-/-mice, demonstrating that the type I IFN system is a major acute antiviral defence. In cell lines derived from IFNAR1 -/-mice, there was no signaling in response to IFN-a or -,B as measured by induction of 2'-5' oligoadenylate synthetase, antiviral, or antiproliferative responses. Importantly, these studies demonstrate that type I IFNs function in the development and responses of myeloid lineage cells, particularly macrophages, and that the IFNAR1 receptor component is essential for antiproliferative and antiviral responses to IFN-a and -1.
Type I interferons (IFNs) are pleiotropic cytokines important in host defence and in physiological processes such as growth and differentiation (1, 2) . These IFNs include 15 subtypes of IFN-a, one IFN-f3, one IFN-w, and in some species several subtypes of IFN-T (trophoblast proteins) (1) (2) (3) . The classification into type I IFN is based on similarities in structure and biological activities, a shared receptor or receptor component, and induction in response to virus (with the probable exception of IFN-T) (1) (2) (3) . Type II IFN (IFN-y) differs from type I IFNs in all of the above respects except for some overlap in biological activities. IFNs protect cells against viral infection, regulate cell proliferation and differentiation, and activate immune effector cells such as natural killer cells and macrophages (1) . Type I IFNs also may affect hemopoiesis (4) (5) (6) : for example, IFN-a/f3 is produced by cultured murine bone marrow (BM) cells in response to colony-stimulating factor 1 (CSF-1) and may suppress or induce differentiation depending on the experimental conditions (6) . IFN-a and -13 are constitutively produced by hemopoietic cells (6) (7) (8) (9) , but direct evidence of an in vivo role for constitutive IEN in hemopoiesis is lacking. Type I IFNs also may regulate the differentiation of other cell types (2, 10) . For instance, the production of and responses to IFNs are repressed in the early embryo and thus are developmentally regulated (2, 11) . Furthermore, in ruminants at least, IFN-T subtypes are important in the maternal recognition of pregnancy (2) .
Individual type I IFNs compete for binding to cell surface receptors and therefore probably share a common receptor component (1) . The cDNA encoding a component of the human type I IFN receptor (12) , designated here as IFNAR1, and its murine homologue (13) (12) .
To investigate the functions of type I IFNs in vivo and their mechanism of action, we have generated mice with a null mutation in the IFNAR1 gene. During the course of this work, another group also published the generation of an IFNAR1 gene "knock-out" mouse and reported a susceptibility to viral infection (19 (Fig. 1A) . Bands of the predicted sizes were also detected in Southern blots of EcoRI-digested DNA probed with MIR and neo (data not shown). ES cell clones containing a targeted IFNAR1 allele were microinjected into Balb/c blastocysts to generate germ-line chimeras, which were bred to Balb/c females to produce heterozygous mice. Northern blots were performed with total RNA extracted from organs by using guanidinium isothiocynate and probed with a 586-bp IFNAR1 cDNA fragment (nucleotides 811-1397) and subsequently with glyceraldehyde-3-phosphate dehydrogenase cDNA (22 
. cultured in Dulbecco's modified Eagle's medium containing 10% (vol/vol) fetal calf serum (FCS), 1% penicillin, and 1% streptomycin (P.A. Biological, Sydney, Australia). BM-derived macrophages (BMM) were generated as a relatively pure and homogeneous population of adherent cells from their nonadherent progenitors (23) (25) .
Antiviral and Antiproliferative Assays. Antiviral activities of IFNs were determined in quadruplicate as the concentration of IFN that provides protection to 50% of the cells. Antiproliferative activities of exogenous IFNs were determined by using BMM stimulated with high levels of CSF-1 (5000 ,ug/ml). Inhibition of this incorporation was tested by adding 10-400 units of IFN-a, 1000 units of IFN-,y, or 100 ng of lipopolysaccharide (LPS, Difco) per ml.
Immunophenotyping. Peripheral blood leukocytes (PBL) (previously incubated with 0.83% NH4Cl for 10 min at 370C to lyse contaminating erythrocytes) and BM cells were labeled with rat monoclonal antibodies anti-Gr-1 (neutrophils) (26) and anti-Mac-1 (macrophage subsets) (27) 
RESULTS
Generation of Mice with a Null Mutation in IFNAR1. The genotypes of mice resulting from heterozygote crosses were confirmed by Southern blots (Fig. 1B) . The expression of IFNAR1 was examined by RT-PCR of total RNA from spleen, liver, and lungs of mice; a band of the expected 570 bp was seen in IFNAR1 +/+ and +/-mice but not in IFNAR1 -/-mice (data for lung RNA only is shown in Fig. 1C (Fig. 2A) . The survival of heterozygous m controls ( Fig. 2A) . By contrast, the IFNAR rapidly: all were alive but moribund 21 hr afte virus, and all were dead 3 hr later ( Fig. 2A) A dosedependent increase in thymidine incorporation was detected after treatment of quiescent IFNAR1 +/+ BMM with graded low doses (80-625 ,ug/ml) of CSF-1 (Fig. 4) . However, IFNARi -/-BMM show a markedly reduced response to these doses of CSF-1 (Fig. 4) . Thus, BMM from IFNAR1 -/-mice Antiproliferative Activity of Exogenous IFNs on BMM. We chose the proliferation of BMM in response to high levels of CSF-1 (5000 ,tg/ml) as a sensitive system to examine the inhibitory activities of exogenous type I IFNs and other factors, since IFNAR1 -/-BMM showed approximately normal stimulation of thymidine incorporation in response to this very high level. IFNAR1 +/+ BMM were inhibited by 95% in response to 12.5 units of mixed IFN-a subtypes per ml and by 99% in response to higher levels (Fig. SA) . IFN-'y and LPS also strongly inhibited proliferation. IFNAR1 -/-BMM were resistant to the antiproliferative effects of up to 400 units of IFN-a per ml, but IFN-,y was still active (Fig. SB) . Surprisingly, LPS also did not inhibit the CSF-1-stimulated thymidine incorporation into IFNAR1 -/-BMM (Fig. SB) , indicating that this effect of LPS on BMM is mediated through IFNARL. Indeed, in several experiments, IFN levels of 400-1000 units/ml were detected in supernatants of LPS-treated BMM in a cytopathic effect reduction bioassay. Responses of BMM from heterozygous mice were similar to those from IFNAR1 +/+ mice (data not shown), indicating no detrimental effect cfrediuced IFNAR1 gene expression on these responses. To ascertain whether different biological responses of IFNs can be differentially regulated in the same cell type, we also examined the antiviral activities of IFNs in BMM. While IFNAR1 +/+ cells developed an antiviral response to as little as 1 unit of IFN-a per ml (Fig. 5C) , the IFNAR1 -/-cells showed no responses to as much as 10,000 units/ml (Fig. SD) .
The antiviral activity of IFN-y was similar (-3 units/ml) in BMM of both genotypes (Fig. 5 C and D 
